BBR Partners’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-305
Closed -$3.73K 206
2023
Q2
$3.73K Hold
305
﹤0.01% 158
2023
Q1
$4.37K Hold
305
﹤0.01% 166
2022
Q4
$4.57K Hold
305
﹤0.01% 175
2022
Q3
$12K Hold
305
﹤0.01% 176
2022
Q2
$23K Hold
305
﹤0.01% 224
2022
Q1
$15K Hold
305
﹤0.01% 248
2021
Q4
$21K Hold
305
﹤0.01% 203
2021
Q3
$44K Hold
305
﹤0.01% 219
2021
Q2
$187K Hold
305
0.01% 187
2021
Q1
$213K Hold
305
0.02% 191
2020
Q4
$229K Buy
+305
New +$213K 0.02% 170

Other funds holding MDVL

BBR Partners's MDVL Position: Q3 2023 in Review

BBR Partners sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2023, closing a stake of 305 shares — an estimated $3.73K sold.

BBR Partners first reported a position in MDVL in Q4 2020 and held it in 11 quarters. The position peaked at $229K in Q4 2020. 19 funds tracked by Wall St. Rank hold MDVL as of Q3 2023.

  • BBR Partners reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • BBR Partners sold 305 MedAvail Holdings, Inc. Common Stock shares in Q3 2023, an estimated $3.73K.
  • BBR Partners first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • BBR Partners's MedAvail Holdings, Inc. Common Stock position peaked at $229K in Q4 2020.
  • 19 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2023.

Based on BBR Partners's 13F filing for Q3 2023, filed 14 Nov 2023.